6-氯-2-(4-氯苯基)咪唑并[1,2-b]吡嗪 | 1844-56-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 6-氯-2-(4-氯苯基)咪唑并[1,2-b]吡嗪
• 英文名称: 6-chloro-2-(4'-chlorophenyl)imidazo<1,2-b>pyridazine
• 英文别名: 6-chloro-2-(4-chlorophenyl)imidazo[1,2-b]pyridazine；6-chloro-2-(4-chloro-phenyl)-imidazo[1,2-b]pyridazine；6-Chlor-2-<4-chlor-phenyl>-imidazo<1,2-b>pyridazin
• CAS: 1844-56-0
• 化学式: C₁₂H₇Cl₂N₃
• 分子量: 264.114
• InChiKey: HYSPSPQAXIZJPJ-UHFFFAOYSA-N

物化性质

• 熔点：
  219 °C
• 密度：
  1.47±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  6-氯-2-(4-氯苯基)咪唑并[1,2-b]吡嗪 在 一氯化碘 作用下， 以 氯仿 为溶剂， 生成 6-chloro-2-(4-chlorophenyl)-3-iodoimidazo[1,2-b]pyridazine
  参考文献：
  名称：

  6-CYCLOAMINO-3-(PYRID-4-YL)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

  摘要：

  该发明涉及与一般式(I)相对应的6-环氨基-3-(吡啶-4-基)咪唑并[1,2-b]吡啶嗪衍生物。其中R2、R3、R7、R8、A、L和B的定义如本文所述。还公开了其制备方法和治疗用途。

  公开号：

  US20100179154A1

文献信息

• [EN] SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR<br/>[FR] LIGANDS SÉLECTIFS DU RÉCEPTEUR D'ANDROSTANE CONSTITUTIF HUMAIN
  申请人：USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I

  公开号：WO2020221380A1

  公开（公告）日：2020-11-05

  The present invention provides a structurally novel class of heterocyclic compounds of general formula I wherein L1 is heteroaryl and L2 is heteroaryl or aryl. The novel compounds are useful in a method of prevention or treatment of a condition which is mediated by the action, or by loss of action, of Constitutive androstane receptor (CAR) receptor or its endogenous ligands. The present invention thus provides the novel compounds for medicinal use, as well as pharmaceutical composition containing said compounds. (I)

  本发明提供了一类结构新颖的杂环化合物，其通用公式为I，其中L1是杂芳基，L2是杂芳基或芳基。这些新颖化合物在预防或治疗由构成雄烷受体（CAR）受体或其内源性配体的作用或作用丧失介导的疾病的方法中是有用的。因此，本发明提供了用于药用的新颖化合物，以及含有所述化合物的药物组合物。(I)
• Imidazo[1,2-b]pyridazines. XXI. Syntheses of some 3-Acylaminomethyl-6-(chloro and iodo)- 2-(substituted phenyl)-imidazo[1,2-b]pyridazines and -imidazo[1,2-a]pyridines and their Interaction with Central and Mitochondrial Benzodiazepine
  作者：Gordon B. Barlin、Les P. Davies、Peter W. Harrison

  DOI：10.1071/c96130

  日期：——

  A series of 3-acylaminomethyl-6-(chloro, iodo and methyl)-2-(phenyl, 4′-t-butylphenyl, 4′-cyclohexyl- phenyl, biphenyl-4′-yl, 4′-chlorophenyl and 4′-iodophenyl)imidazo[1,2-b]pyridazines and imidazo[1,2- a]pyridines has been prepared and examined for interaction with central and mitochondrial (peripheral- type) benzodiazepine receptors. The imidazo[1,2-b]pyridazines were generally more selective for the mitochondrial receptors than the corresponding imidazo[1,2-a]pyridines. Of these compounds, 3- acetamidomethyl-2-(biphenyl-4′-yl)-6-chloroimidazo[1,2-b]pyridazine (9) proved to be the most selective in studies of the displacement of [3H]diazepam from peripheral-type and central benzodiazepine receptors (IC50 2·8 nM and 0% displacement at 1000 nM, respectively).

  4′-叔丁基苯基、4′-环己基苯基、4′-联苯基、 4′-氯苯基和 4′-环己基苯基、4′-联苯基、4′-氯苯基和 4′-碘苯基）咪唑并[1,2-b]哒嗪 和咪唑并[1,2-a]吡啶的相互作用进行了研究。 和咪唑并[1,2-a]吡啶的相互作用进行了研究。 苯并二氮杂卓受体的相互作用。这些 咪唑并[1,2-b]哒嗪对线粒体受体的选择性通常更高。 比相应的咪唑并[1,2-b]哒嗪对线粒体受体的选择性更强。 咪唑并[1,2-a]吡啶对线粒体受体的选择性更强。在这些化合物中 3- 乙酰胺基甲基-2-（联苯-4′-基）-6-氯咪唑并[1,2-b]哒嗪 (9) (9) 在研究[3H]二氮杂卓的位移时被证明是最具选择性的。 [3H]地西泮从外周型和中枢型苯并二氮杂卓受体（IC 的选择性（IC50 2-8 nM 和 0% displacement at 1000 nM）。
• Direct Arylation of Imidazo[1,2-<i>b</i>]pyridazines: Microwave-Assisted One-Pot Suzuki Coupling/Pd-Catalysed Arylation
  作者：Ahmed El Akkaoui、Sabine Berteina-Raboin、Abderrahim Mouaddib、Gérald Guillaumet

  DOI：10.1002/ejoc.200900849

  日期：2010.2

  Direct intermolecular C-H arylation of 6-chloroimidazo[1,2-b]-pyridazine in its 3-position was achieved, and the tolerance to reaction conditions in the presence of chloro groups was investigated. Various 3-(hetero)arylimidazo[1,2-b]pyridazines were synthesized in good to excellent yields. This methodology was successfully applied to the synthesis of 3,6-di-and 2,3,6-trisubstituted imidazo[1,2-b]pyridazines

  实现了 6-氯咪唑并[1,2-b]-哒嗪在其 3-位的直接分子间 CH 芳基化，并研究了在氯基团存在下对反应条件的耐受性。各种 3-（杂）芳基咪唑并 [1,2-b] 哒嗪以良好到极好的产率合成。该方法通过微波辅助、一锅、两步 Suzuki 交叉偶联成功应用于合成 3,6-二和 2,3,6-三取代咪唑并[1,2-b]哒嗪/钯催化的芳基化过程。
• Barlin, Gordon B.; Davies, Les P.; Ireland, Stephen J., Australian Journal of Chemistry, 1992, vol. 45, # 4, p. 731 - 749
  作者：Barlin, Gordon B.、Davies, Les P.、Ireland, Stephen J.、Ngu, Maria M. L.、Zhang, Jiankuo

  DOI：——

  日期：——
• SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR
  申请人：USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I.

  公开号：US20220185822A1

  公开（公告）日：2022-06-16

  A structurally novel class of heterocyclic compounds of general formula I wherein L1 is heteroaryl and L2 is heteroaryl or aryl is disclosed. The novel compounds are useful in a method of prevention or treatment of a condition that is mediated by the action, or by loss of action of Constitutive androstane receptor (CAR) receptor or its endogenous ligands. The present invention provides the novel compounds for medicinal use as well as pharmaceutical composition containing the compounds.